Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies

Por Peter Nash, Laura C. Coates, Roy Fleischmann, Kim A. Papp, Juan Jesus Gomez-Reino, Keith S. Kanik, Cunshan Wang, Joseph Wu, Sujatha Menon, Thijs Hendrikx, William C. Ports
Publicado em 2018-11-01

Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3)

Por Peter Nash, Philip J. Mease, Iain B. McInnes, Proton Rahman, Christopher T. Ritchlin, Ricardo Blanco, Eva Dokoupilova, Mats Andersson, Radhika Kajekar, Shephard Mpofu, Luminita Pricop, on behalf of the FUTURE 3 study group
Publicado em 2018-03-01